Clinical impact of infections caused by ESBL-producing E. coli and K. pneumoniae (Q43773083)

26 November 2017

title

Clinical impact of infections caused by ESBL-producing E. coli and K. pneumoniae (English)

1 reference

26 November 2017

0 references

5

Petra Gastmeier

1 reference

26 November 2017

Axel Kola

1

1 reference

26 November 2017

Oliver Maciejewski

series ordinal

2

1 reference

26 November 2017

Dorit Sohr

series ordinal

3

1 reference

26 November 2017

Stefan Ziesing

series ordinal

4

1 reference

26 November 2017

publication date

21 June 2007

1 reference

Scandinavian Journal of Infectious Diseases

26 November 2017

published in

1 reference

26 November 2017

volume

39

1 reference

26 November 2017

issue

11-12

1 reference

26 November 2017

page(s)

975-982

1 reference

Extended-spectrum beta-lactamases: a clinical update

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Extended-spectrum beta-lactamases: the European experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Epidemiology and risk factors for extended-spectrum beta-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

ASA physical status classifications: a study of consistency of ratings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540701466140

10.1080/00365540701466140

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference